Dexcom, Inc., a leading company in glucose biosensing, has announced a strategic collaboration with ŌURA, the manufacturer of a prominent smart ring, to enhance metabolic health management. This partnership will enable a two-way data flow between Dexcom glucose biosensors, its associated apps, and the Oura Ring along with its accompanying app. The goal is to provide users with a comprehensive view of their overall health by integrating glucose data with metrics such as vital signs, sleep patterns, stress levels, heart health, and physical activity.
Dexcom is making a significant financial commitment by investing $75 million in ŌURA’s Series D funding round. This investment places ŌURA’s valuation above $5 billion. The integration of Dexcom’s glucose data with the biometric data collected by the Oura Ring is intended to give users a more detailed understanding of how lifestyle choices impact their glucose levels. This data integration is anticipated to attract a broader customer base interested in understanding the relationship between their activities, nutrition, and glucose levels.
The partnership will see the launch of integrations that allow data to flow seamlessly between Dexcom and ŌURA’s products. This integration is expected to be available in the first half of 2025. The companies also plan to promote and sell each other’s products, potentially reaching millions of new users focused on improving their metabolic health.
ŌURA has reported that a significant portion of its user base is interested in understanding the effects of dietary choices on health. The collaboration with Dexcom is expected to empower users to make informed decisions by highlighting correlations between activities such as sleep and exercise and their glucose levels. This personalized guidance is based on the understanding that individuals respond differently to the same foods and activities.
Dexcom has been at the forefront of glucose biosensing technology for over 25 years, introducing products like Stelo, the first glucose biosensor approved for use without a prescription in the U.S. Globally, Dexcom has over 2.5 million active users who rely on its technology to manage their health. For ŌURA, the year has marked significant business growth, with the company expecting to see substantial increases in sales and profitability.
The collaboration between Dexcom and ŌURA aims to address the widespread issue of suboptimal metabolic health, which affects a large portion of the population and increases the risk of various health conditions. By combining advanced medical-grade technology with sophisticated software, the partnership seeks to empower consumers with valuable health information.
For more information about Dexcom, check out their website here. Information about ŌURA is available on their website here.
